Top Industry Leaders in the Asia Pacific Blood Glucose Monitoring Market
Nov 2023Abbott (US) Launched the FreeStyle Libre 3 System in China and South Korea, expanding their reach for CGM technology in the region.Partnered with healthcare providers in India to improve access to their BGM devices and educational resources for diabetes management.
Roche Diagnostics (Switzerland) Introduced their Accu-Chek® Guide meter with Bluetooth® connectivity, enabling data sharing with healthcare providers in Australia and New Zealand.Focused on developing next-generation BGM systems with integrated AI features for personalized diabetes management.
FGM Sensing Systems (Australia) Received CE Mark approval for their Eversense® CGM system, offering a long-lasting sensor and improved user experience for patients in Europe and Southeast Asia.Collaborated with research institutions in Japan to explore the potential of CGM data for predicting and preventing diabetes complications.
ACON Laboratories (US) Launched their OnCall® Elite Glucometer with advanced features like micro blood sample size and voice guidance, catering to a broader market segment in Asia.Partnered with online pharmacies and distributors to increase the accessibility of their BGM devices in remote areas.
Terumo Corporation (Japan) Introduced their new TrueMetrix® Air Blood Glucose Monitoring System with ketone test strip option, providing comprehensive metabolic monitoring to patients in Taiwan and Indonesia.Focused on developing smart BGM devices with cloud-based data management and telehealth integration for improved diabetes care coordination.
List of Asia Pacific Blood Glucose Monitoring Key Companies in the Market
- Abbott Laboratories
- Arkay Inc.
- Bayer Healthcare AG
- Hoffmann-La Roche
- Goldsite Diagnostics Inc.
- GlySure Ltd
- Sphere Medical
- Dexcom
- LifeScan
